162 related articles for article (PubMed ID: 34581793)
1. SELECTION OF PFCRT 76T AND PFMDR1 86Y MUTANT PLASMODIUM FALCIPARUM AFTER TREATMENT OF UNCOMPLICATED MALARIA WITH ARTESUNATE-AMODIAQUINE IN REPUBLIC OF GUINEA.
Beavogui AH; Diawara EY; Cherif MS; Delamou A; Diallo N; Traore A; Millimouno P; Camara D; Sylla MM; Toure AA; Diallo MS; Toure S; Togo A; Camara G; Kourouma K; Sagara I; Dicko A; Djimde A
J Parasitol; 2021 Sep; 107(5):778-782. PubMed ID: 34581793
[TBL] [Abstract][Full Text] [Related]
2. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
3. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
[TBL] [Abstract][Full Text] [Related]
4. Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar.
Fröberg G; Jörnhagen L; Morris U; Shakely D; Msellem MI; Gil JP; Björkman A; Mårtensson A
Malar J; 2012 Sep; 11():321. PubMed ID: 22966778
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
[TBL] [Abstract][Full Text] [Related]
6. Selection of
Maiga H; Grivoyannis A; Sagara I; Traore K; Traore OB; Tolo Y; Traore A; Bamadio A; Traore ZI; Sanogo K; Doumbo OK; Plowe CV; Djimde AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205228
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Umesumbu SE; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
Malar J; 2021 Mar; 20(1):144. PubMed ID: 33706773
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
9. In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria.
Folarin OA; Bustamante C; Gbotosho GO; Sowunmi A; Zalis MG; Oduola AM; Happi CT
Acta Trop; 2011 Dec; 120(3):224-30. PubMed ID: 21920347
[TBL] [Abstract][Full Text] [Related]
10. Pfcrt 76T and pfmdr1 86Y allele frequency in Plasmodium falciparum isolates and use of self-medication in a rural area of Gabon.
Mawili-Mboumba DP; Ndong Ngomo JM; Maboko F; Guiyedi V; Mourou Mbina JR; Kombila M; Bouyou Akotet MK
Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):729-34. PubMed ID: 25249358
[TBL] [Abstract][Full Text] [Related]
11. In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.
Thwing JI; Odero CO; Odhiambo FO; Otieno KO; Kariuki S; Ord R; Roper C; McMorrow M; Vulule J; Slutsker L; Newman RD; Hamel MJ; Desai M
Trop Med Int Health; 2009 Mar; 14(3):294-300. PubMed ID: 19187521
[TBL] [Abstract][Full Text] [Related]
12. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
[TBL] [Abstract][Full Text] [Related]
13. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa.
Holmgren G; Hamrin J; Svärd J; Mårtensson A; Gil JP; Björkman A
Infect Genet Evol; 2007 Sep; 7(5):562-9. PubMed ID: 17467344
[TBL] [Abstract][Full Text] [Related]
14. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of antimalarial combinations for treatment of uncomplicated malaria in children in Bangui, Central African Republic].
Nambei WS; Lango Yaya E; Pounguinza S; Achonduh O; Bogon A; Lengande R; Evehe MS; Ekollo Mbange AH; Mbacham W
Med Sante Trop; 2013; 23(3):313-9. PubMed ID: 24122669
[TBL] [Abstract][Full Text] [Related]
16. Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso.
Danquah I; Coulibaly B; Meissner P; Petruschke I; Müller O; Mockenhaupt FP
Acta Trop; 2010 Apr; 114(1):63-6. PubMed ID: 20060374
[TBL] [Abstract][Full Text] [Related]
17. [Pcr-rflp genotyping of
Ravaoarisoa É; Andrianaranjaka VHI; Ramanantsahala AD; Rakotomanga TA; Ralinoro F; Rakotosaona R; Randrianarivo RH; Rakoto DAD; Jeannoda V; Ratsimbasoa A
Med Trop Sante Int; 2022 Jun; 2(2):. PubMed ID: 35919251
[TBL] [Abstract][Full Text] [Related]
18. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia.
Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S
Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992
[TBL] [Abstract][Full Text] [Related]
19. The role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011.
Eyase FL; Akala HM; Ingasia L; Cheruiyot A; Omondi A; Okudo C; Juma D; Yeda R; Andagalu B; Wanja E; Kamau E; Schnabel D; Bulimo W; Waters NC; Walsh DS; Johnson JD
PLoS One; 2013; 8(5):e64299. PubMed ID: 23675533
[TBL] [Abstract][Full Text] [Related]
20. Sustained
Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
